These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 29425752)
1. Management of Facial Pyoderma Gangrenosum Using Platelet-Rich Fibrin: A Technical Report. Fortunato L; Barone S; Bennardo F; Giudice A J Oral Maxillofac Surg; 2018 Jul; 76(7):1460-1463. PubMed ID: 29425752 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report. Giudice A; Antonelli A; Muraca D; Fortunato L Indian J Dent Res; 2020; 31(5):813-818. PubMed ID: 33433526 [TBL] [Abstract][Full Text] [Related]
3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
4. Treatment of postsurgical pyoderma gangrenosum with a high-potency topical steroid. Hawryluk EB; Penn SK; Wasko MC; Johnson JT; Ferris LK Ear Nose Throat J; 2010 Jun; 89(6):E5-7. PubMed ID: 20556729 [TBL] [Abstract][Full Text] [Related]
5. Topical tacrolimus in the management of peristomal pyoderma gangrenosum. Lyon CC; Stapleton M; Smith AJ; Mendelsohn S; Beck MH; Griffiths CE J Dermatolog Treat; 2001 Mar; 12(1):13-7. PubMed ID: 12171681 [TBL] [Abstract][Full Text] [Related]
13. Treatment of pyoderma gangrenosum with topical factor XIII. Hoetzenecker W; Guenova E; Mitev V; Schanz S; Ulmer A; Fierlbeck G Eur J Dermatol; 2013; 23(5):653-7. PubMed ID: 24135449 [TBL] [Abstract][Full Text] [Related]
14. Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment of refractory leg ulcers: a prospective cohort study. Pinto NR; Ubilla M; Zamora Y; Del Rio V; Dohan Ehrenfest DM; Quirynen M Platelets; 2018 Jul; 29(5):468-475. PubMed ID: 28727481 [TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum: Classic and emerging therapies. Soto Vilches F; Vera-Kellet C Med Clin (Barc); 2017 Sep; 149(6):256-260. PubMed ID: 28629662 [TBL] [Abstract][Full Text] [Related]
16. Utility of platelet rich fibrin gel therapy in nonhealing ulcer secondary to ecthyma gangrenosum. Rajan M B; Singh S Dermatol Ther; 2019 May; 32(3):e12887. PubMed ID: 30942949 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Pediatric Pyoderma Gangrenosum With Modified Negative Pressure Wound Therapy and Intralesional Corticosteroids: A Case Report. Barker CS; Santa Lucia G; Brunette G; Wine Lee L J Wound Ostomy Continence Nurs; 2022 Sep-Oct 01; 49(5):488-491. PubMed ID: 36108234 [TBL] [Abstract][Full Text] [Related]
18. Can snus (Swedish moist snuff) be used as a treatment of Pyoderma gangrenosum? Kluger N Med Hypotheses; 2012 May; 78(5):619-20. PubMed ID: 22341940 [TBL] [Abstract][Full Text] [Related]
19. A novel topical therapy for resistant and early peristomal pyoderma gangrenosum. Pearson WA; Prentice DA; Sinclair DL; Lim LY; Carville KJ Int Wound J; 2019 Oct; 16(5):1136-1143. PubMed ID: 31298491 [TBL] [Abstract][Full Text] [Related]
20. Precise Intradermal Injection of Nanofat-Derived Stromal Cells Combined with Platelet-Rich Fibrin Improves the Efficacy of Facial Skin Rejuvenation. Liang ZJ; Lu X; Li DQ; Liang YD; Zhu DD; Wu FX; Yi XL; He N; Huang YQ; Tang C; Li HM Cell Physiol Biochem; 2018; 47(1):316-329. PubMed ID: 29768259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]